Time to Surgery - the Impact of Waiting Time on Outcome After Colorectal Cancer Treatment
Tidop
1 other identifier
observational
40,000
1 country
1
Brief Summary
We aim to perform a register-based, observational cohort study to investigate whether it is safe to delay start of treatment with a curative intention after a colorectal cancer diagnosis. Our hypothesis is that delaying start of treatment until 4-8 weeks is as safe as starting treatment within four weeks after a colorectal cancer diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2020
CompletedFirst Posted
Study publicly available on registry
September 30, 2020
CompletedStudy Start
First participant enrolled
October 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2021
CompletedDecember 2, 2021
December 1, 2021
9 months
September 2, 2020
December 1, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Overall survival
Overall survival
3 years
Secondary Outcomes (4)
Length of stay
90 days
Re-operations within 3 months
90 days
Re-admissions within 3 months
90 days
Radical surgery
90 days
Study Arms (1)
Colorectal cancer patients
Patients diagnosed with colonrectal cancer between 2008-2016
Interventions
Eligibility Criteria
All patients registered with a diagnosis of colorectal cancer in Sweden between 2008-2016
You may qualify if:
- Diagnosed with colorectal cancer 2008-2016 in Sweden
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sahlgrenska University Hospital
Gothenburg, 41132, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eva Angenete
Sahlgrenska Universitetssjukhuset
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of surgery
Study Record Dates
First Submitted
September 2, 2020
First Posted
September 30, 2020
Study Start
October 15, 2020
Primary Completion
July 15, 2021
Study Completion
September 15, 2021
Last Updated
December 2, 2021
Record last verified: 2021-12